IMARC Group, a leading market research company, has recently releases report titled “Pediatric Interventional Cardiology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global pediatric interventional cardiology market share, size, growth, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Industry Overview of Pediatric Interventional Cardiology
Pediatric interventional cardiology utilizes catheters and other advanced technologies to access and repair heart-related issues among children. It minimizes trauma to young patients and often results in shorter hospital stays. It plays a vital role in enhancing the overall quality of life for young patients and reducing the long-term health risks associated with heart problems. Besides this, it can address a wide range of congenital heart defects, valve abnormalities, and other cardiac conditions that affect infants, children, and adolescents.
How Big Is the Pediatric Interventional Cardiology Market?
The global pediatric interventional cardiology market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.
Request Sample Copy of This Report: https://www.imarcgroup.com/pediatric-interventional-cardiology-market/requestsample
What are the growth prospects and trends in the pediatric interventional cardiology industry?
Presently, the rising awareness about the benefits of minimally invasive (MI) techniques among both parents and healthcare providers, such as reduced incision, quick recovery, and less pain, represents one of the primary factors strengthening the market growth. In line with this, the growing demand for pediatric interventional cardiology due to improved healthcare infrastructure across the globe is offering a positive market outlook.
Apart from this, the rising prevalence of congenital heart diseases and other cardiac conditions in children is bolstering the growth of the market. Moreover, technological advancements in pediatric interventional cardiology equipment and techniques, such as advanced catheters, imaging technologies, and three-dimensional (3D) visualization tools to improve precision, are offering lucrative growth opportunities to industry investors.
Besides this, the rising demand for improved patient care solutions among individuals is impelling the growth of the market.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Device Type:
- Closure Devices
- Transcatheter Heart Valves
- Atherectomy Devices
- Catheters
- Balloons
- Stents
- Others
Breakup by Procedure:
- Catheter-Based Valve Implantation
- Congenital Heart Defect Correction
- Angioplasty
- Coronary Thrombectomy
- Others
Breakup by End Use:
- Clinical Testing Laboratories
- Hospitals
- Cardiac Centers
- Pediatric Clinics
- Research Institutions
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, NuMED Inc., Siemens Healthineers AG, Terumo Corporation and W. L. Gore & Associates Inc.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
